论文部分内容阅读
自1997年10月以来,我们选用秦皇岛港口医院刘建一副主任医师倡导的心痛定(Nifedpine)阿替洛尔(Aetnolol)与氢氯噻嗪(Hydrochloroth-iazidum)简称NAH方案治疗单一药物或两种以上短效制剂不能平稳控制的Ⅰ、Ⅱ期原发性高血压病
Since October 1997, we selected Nifedpine, Aetnolol and Hydrochlorothiazide (NAH), referred to by the deputy chief physician of Liu Jianyi at Qinhuangdao Port Hospital, to treat single drug or two or more short-acting agents I, II can not be controlled smoothly in patients with essential hypertension